Evidence map›Paper›PMID 36564386›Full record

ArticleNature communications2022

Paratype: a genotyping tool for Salmonella Paratyphi A reveals its global genomic diversity.

Arif M Tanmoy, Yogesh Hooda, Mohammad S I Sajib, Kesia E da Silva, Junaid Iqbal, Farah N Qamar, Stephen P Luby, Gordon Dougan, Zoe A Dyson, Stephen Baker and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A contemporary genomic snapshot ofMicrobial genomics · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Typhoid fever.Nature reviews. Disease primers · 2023
    Review
  13. Article
  14. Article
  15. Genomic Surveillance ofOpen forum infectious diseases · 2023
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 6 countries.

Arif M Tanmoy *Child Health Research Foundation, Dhaka, Bangladesh.ORCID 0000-0002-7769-8035
Yogesh Hooda *Child Health Research Foundation, Dhaka, Bangladesh.
Mohammad S I SajibChild Health Research Foundation, Dhaka, Bangladesh.
Kesia E da SilvaDivision of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Junaid IqbalDepartment of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan.ORCID 0000-0002-5014-2176
Farah N QamarDepartment of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Stephen P LubyDivision of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0001-5385-899X
Gordon DouganWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Zoe A DysonWellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.ORCID 0000-0002-8887-3492
Stephen BakerCambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0003-1308-5755
Denise O GarrettApplied Epidemiology Team, Sabin Vaccine Institute, Washington, DC, USA.
Jason R AndrewsDivision of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-5967-251X
Samir K SahaChild Health Research Foundation, Dhaka, Bangladesh.
Senjuti SahaChild Health Research Foundation, Dhaka, Bangladesh. senjutisaha@chrfbd.org.ORCID 0000-0001-6087-6766
Stanford University · USAga Khan University · PKBangladesh Shishu (Children) Hospital & Institute · BDChild Health Research Foundation · BDUniversity of Cambridge · GBErasmus MC · NLSabin Vaccine Institute · USWellcome Sanger Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salmonella Paratyphi A, the primary etiology of paratyphoid, is estimated to cause 3.4 million infections annually, worldwide. With rising antimicrobial resistance and no licensed vaccines, genomic surveillance is key to track and monitor transmission, but there is currently no reliable genotyping framework for this pathogen. Here, we sequence 817 isolates from South Asia and add 562 publicly available genomes to build a global database representing 37 countries, covering 1917-2019. We develop a single nucleotide polymorphism-based genotyping scheme, Paratype, that segregates Salmonella Paratyphi A population into three primary and nine secondary clades, and 18 genotypes. Each genotype is assigned a unique allele definition located on an essential gene. Using Paratype, we identify spatiotemporal genomic variation and antimicrobial resistance markers. We release Paratype as an open-access tool that can use raw read files from both Illumina and Nanopore platforms, and thus can assist surveillance studies tracking Salmonella Paratyphi A across the globe.

Indexed as

Anti-Infective AgentsParatyphoid FeverGenomicsGenotypeHumansSalmonella paratyphi AAnti-Infective Agents

Identifiers

PMID36564386
PMCPMC9782287
OpenAlexW4312155015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.